Free Trial

Kairos Pharma (KAPA) Institutional Ownership

Kairos Pharma logo
$0.48 -0.01 (-2.05%)
Closing price 05/15/2026 04:10 PM Eastern
Extended Trading
$0.50 +0.01 (+2.65%)
As of 05/15/2026 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Kairos Pharma (NYSEAMERICAN:KAPA)

Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$151.18K
Number of
Institutional Sellers
(last 12 months)
0
Get KAPA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kairos Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KAPA Institutional Buying and Selling by Quarter

Kairos Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026XTX Topco Ltd48,494$34K0.0%+290.8%0.233%
12/15/2025 FNY Investment Advisers LLC23,500$27K0.0%N/A0.113%
11/14/2025Two Sigma Investments LP45,789$54K0.0%N/A0.221%
8/12/2025XTX Topco Ltd62,746$44K0.0%N/A0.307%
5/15/2025Armistice Capital LLC1,404,000$1.31M0.0%N/A10.248%


KAPA Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Kairos Pharma shares: Armistice Capital LLC ($1.31M), Two Sigma Investments LP ($54K), and XTX Topco Ltd ($34K), FNY Investment Advisers LLC ($27K).Learn more on Kairos Pharma's institutional investors.

The following institutional investors have purchased Kairos Pharma's stock in the last 24 months: Armistice Capital LLC ($1.40M), XTX Topco Ltd ($98.83K), Two Sigma Investments LP ($45.79K), and FNY Investment Advisers LLC ($23.50K).

Institutional investors have bought a total of 168,121 shares in the last 24 months. This purchase volume represents approximately $151.18K in transactions.



This page (NYSEAMERICAN:KAPA) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners